Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry B Gernsheimer

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Shock (Augusta, Ga.)|September 19, 2006
The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trialAvery B Nathens, Theresa A Nester, Gordon D Rubenfeld, et al.
Transfusion|September 17, 2013
The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationLisa K Vande Vusse, David K Madtes, Katherine A Guthrie, et al.
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 31, 2007
Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patientsEdie Y Chan, Anne M Larson, Terry B Gernsheimer, et al.
American Journal of Hematology|July 2, 2009
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)Vinod A Pullarkat, Terry B Gernsheimer, Jeffrey S Wasser, et al.
Transfusion|May 9, 2012
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literatureKerry L O'Brien, Shalini E Pereira, Jeffrey Wagner, et al.
Transfusion|December 29, 2018
Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategyMonica B Pagano, Brennan L Katchatag, Shiva Khoobyari, et al.
Transfusion|October 7, 2024
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trialJacqueline N Poston, Siobhan P Brown, Amy Sarah Ginsburg, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignanciesJacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Blood|March 11, 2011
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaSarah J Barsam, Bethan Psaila, Marc Forestier, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Shock (Augusta, Ga.)|September 19, 2006
The effects of leukoreduced blood transfusion on infection risk following injury: a randomized controlled trialAvery B Nathens, Theresa A Nester, Gordon D Rubenfeld, et al.
Transfusion|September 17, 2013
The association between red blood cell and platelet transfusion and subsequently developing idiopathic pneumonia syndrome after hematopoietic stem cell transplantationLisa K Vande Vusse, David K Madtes, Katherine A Guthrie, et al.
Transfusion|October 11, 2011
RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)Jenny M Despotovic, Michele P Lambert, Jay H Herman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 31, 2007
Recipient and donor factors influence the incidence of graft-vs.-host disease in liver transplant patientsEdie Y Chan, Anne M Larson, Terry B Gernsheimer, et al.
American Journal of Hematology|July 2, 2009
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531)Vinod A Pullarkat, Terry B Gernsheimer, Jeffrey S Wasser, et al.
Transfusion|May 9, 2012
Transfusion-associated graft-versus-host disease in a liver transplant recipient: an unusual presentation and review of the literatureKerry L O'Brien, Shalini E Pereira, Jeffrey Wagner, et al.
Transfusion|December 29, 2018
Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategyMonica B Pagano, Brennan L Katchatag, Shiva Khoobyari, et al.
Transfusion|October 7, 2024
Analysis of bleeding outcomes in patients with hypoproliferative thrombocytopenia in the A-TREAT clinical trialJacqueline N Poston, Siobhan P Brown, Amy Sarah Ginsburg, et al.
Research and Practice in Thrombosis and Haemostasis|April 26, 2024
Fewer severe infections with tranexamic acid in patients with hematologic malignanciesJacqueline N Poston, Siobhan P Brown, Anton Ilich, et al.
Blood|March 11, 2011
Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopeniaSarah J Barsam, Bethan Psaila, Marc Forestier, et al.
Pageof 4